Sumitomo Chemical Intrinsic Value
SUMICHEM • Chemicals
Current Stock Price
₹393.25
Primary Intrinsic Value
₹170.88
Market Cap
₹196.2K Cr
-70.0%
Downside
Median Value
₹117.97
Value Range
₹79 - ₹228
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
SUMICHEM Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹170.88 | ₹136.70 - ₹205.06 | -56.5% | EPS: ₹14.24, Sector P/E: 12x |
| Book Value Method | asset | ₹78.65 | ₹70.79 - ₹86.52 | -80.0% | Book Value/Share: ₹58.22, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹117.97 | ₹106.17 - ₹129.77 | -70.0% | Revenue/Share: ₹77.68, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹157.30 | ₹141.57 - ₹173.03 | -60.0% | EBITDA: ₹1028.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹157.30 | ₹125.84 - ₹188.76 | -60.0% | CF Growth: 1.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹117.97 | ₹106.17 - ₹129.77 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹117.97 | ₹106.17 - ₹129.77 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹228.30 | ₹205.47 - ₹251.13 | -41.9% | ROE: 24.5%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹117.97 | ₹106.17 - ₹129.77 | -70.0% | EPS: ₹14.24, BVPS: ₹58.22 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
SUMICHEM Intrinsic Value Analysis
What is the intrinsic value of SUMICHEM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sumitomo Chemical (SUMICHEM) is ₹117.97 (median value). With the current market price of ₹393.25, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹78.65 to ₹228.30, indicating ₹78.65 - ₹228.30.
Is SUMICHEM undervalued or overvalued?
Based on our multi-method analysis, Sumitomo Chemical (SUMICHEM) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 32.13 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 24.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 23.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.98x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Sumitomo Chemical
Additional stock information and data for SUMICHEM
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹453 Cr | ₹257 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹757 Cr | ₹547 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹389 Cr | ₹226 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹222 Cr | ₹77 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹425 Cr | ₹284 Cr | Positive Free Cash Flow | 8/10 |